Clinical Trial Update: Herpevac Neonatal Substudy

View source ↗

Summary

The Herpevac neonatal substudy clinical trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex

Drugs mentioned

• Herpevac (HSV-2 glycoprotein B vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Simplex | Status: TERMINATED